272TiP HARMONIA SOLTI-2101 / AFT-58: A head-to-head phase III study comparing ribociclib (RIB) and palbociclib (PAL) in patients (pts) with hormone receptor-positive/HER2-negative/HER2-enriched (HR+/HER2-/HER2-E) advanced breast cancer (ABC)

• DOI: 10.1016/j.annonc.2022.07.1856
• Publication Date: 2022-09-13T22:27:09Z
• Authors: T. Pascual; D.G. Stover; A. Thuerigen; C.M. Perou; E.M. Ciruelos; A. Casas Fernande...; P. Spears; E. Roux; H. Hu; Y-S. Lu; S.M. Tolaney; A. Partridge; G. Villacampa Jav...; J.M. Ferrero Cafiero; L. Carey; A. Prat
• Keywords: 03 medical and health sciences; 0302 clinical medicine